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Microglia activation in the offspring of prenatal Poly I: C exposed rats: a
PET imaging and immunohistochemistry study
Abstract
Background The well-known ‘pyrotherapy’ of Julius Wagner-Jauregg might be the beginning of the study on
the immunological concepts of schizophrenia. As the primary immune effector cells in the brain, microglia
play a pivotal role in neuroinflammatory processes. Maternal viral infection during pregnancy is associated
with an increased risk for psychiatric disorders with presumed neurodevelopmental origin, including autism
spectrum disorders and schizophrenia. The present study was to quantify microglia activation in vivo in the
mature offspring of rats exposed to polyriboinosinic–polyribocytidilicacid (Poly I:C) during pregnancy using
11C-PK11195 positron emission tomography (PET) and immunohistochemistry.
Objective The study aimed to quantify microglia activation in vivo in the prefrontal cortex and hippocampus
in mature offspring of prenatal Poly I:C exposed rats.
Methods Offspring of Poly I:C-treated dams were the model group, offspring of saline-treated dams were the
control group. Behavioural test for two groups was taken by spontaneous activity, prepulse inhibition (PPI)
and latent inhibition (LI) test (including active avoidance conditioning task and passive avoidance
conditioning task). Randomly selected successful model rats were assessed by behavioural test in the model
group and control group rats. 11C-PK11195 micro-PET/CT and immunohistochemistry were performed on
the selected rats to measure microglia activation.
Results The treatment group showed hyperlocomotion and deficits in PPI and LI compared with the control
group. The treatment group also showed an increased 11C-PK11195 uptake ratio in the prefrontal cortex
(t=−3.990, p=0.003) and hippocampus (t=−4.462, p=0.001). The number of activated microglia cells was
significantly higher in the treatment group than in the control group (hippocampus: t=8.204, p
Conclusions The present study demonstrated microglia activation in vivo in the prefrontal cortex and
hippocampus in mature offspring of prenatal Poly I:C exposed rats. This study suggests that microglia
activation may play a possible or potential role in the pathogenesis of schizophrenia.
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AbsTrACT
background The well-known ‘pyrotherapy’ of Julius 
Wagner-Jauregg might be the beginning of the study 
on the immunological concepts of schizophrenia. As the 
primary immune effector cells in the brain, microglia play 
a pivotal role in neuroinflammatory processes. Maternal 
viral infection during pregnancy is associated with an 
increased risk for psychiatric disorders with presumed 
neurodevelopmental origin, including autism spectrum 
disorders and schizophrenia. The present study was to 
quantify microglia activation in vivo in the mature offspring 
of rats exposed to polyriboinosinic–polyribocytidilicacid 
(Poly I:C) during pregnancy using 11C-PK11195 positron 
emission tomography (PET) and immunohistochemistry.
Objective The study aimed to quantify microglia activation 
in vivo in the prefrontal cortex and hippocampus in mature 
offspring of prenatal Poly I:C exposed rats.
Methods Offspring of Poly I:C-treated dams were the 
model group, offspring of saline-treated dams were the 
control group. Behavioural test for two groups was taken 
by spontaneous activity, prepulse inhibition (PPI) and latent 
inhibition (LI) test (including active avoidance conditioning 
task and passive avoidance conditioning task). Randomly 
selected successful model rats were assessed by 
behavioural test in the model group and control group rats. 
11C-PK11195 micro-PET/CT and immunohistochemistry 
were performed on the selected rats to measure microglia 
activation.
results The treatment group showed hyperlocomotion 
and deficits in PPI and LI compared with the control 
group. The treatment group also showed an increased 
11C-PK11195 uptake ratio in the prefrontal cortex 
(t=−3.990, p=0.003) and hippocampus (t=−4.462, 
p=0.001). The number of activated microglia cells was 
significantly higher in the treatment group than in the 
control group (hippocampus: t=8.204, p<0.001; prefrontal: 
t=6.995, p<0.001). Within the treatment group, there 
were significant correlations between the behavioural 
parameters and the activation of microglia as measured by 
PET and immunohistochemistry.
Conclusions The present study demonstrated microglia 
activation in vivo in the prefrontal cortex and hippocampus 
in mature offspring of prenatal Poly I:C exposed rats. 
This study suggests that microglia activation may 
play a possible or potential role in the pathogenesis of 
schizophrenia.
InTrOduCTIOn
The well-known ‘pyrotherapy’ of Julius 
Wagner-Jauregg might be the beginning of 
the study on the immunological concepts of 
schizophrenia (SCZ). Our previous studies 
reported elevated serum levels of interleu-
kin-1β (IL-1β) and tumour necrosis factor 
(TNF)-α (TNF-α), increased nuclear factor-кB 
(NF-κB) activation and its mRNA expression, 
and activated Th17 cells in peripheral blood 
mononuclear cells in patients with first-epi-
sode SCZ.1 A human postmortem study has 
shown increased cytokine levels in the brains 
of patients with SCZ.2 As the primary immune 
effector cells in the brain, microglia play a 
pivotal role in neuroinflammatory processes.3
Maternal viral infection during pregnancy 
is associated with an increased risk of psychi-
atric disorders with presumed neurodevel-
opmental origin, including autism spectrum 
disorders and SCZ.4 Bilbo and colleauges 
have hypothesised that subsets of microglia 
are permanently maintained in an activated 
or primed state into adulthood as a conse-
quence of prenatal infection, and that a 
subsequent immune challenge in adulthood 
can cause exaggerated levels of cytokines 
from these already primed microglia.5 6
Recently, a great deal of interest has been 
centred on the establishment of neurode-
velopmental rodent models in which the 
basic experimental manipulation takes 
the form of prenatal exposure to infection 
and/or immune activation.7 In addition to 
the influenza infection animal model,8 an 
animal model has been increasingly used 
in SCZ research: offspring of female mice 
that were administered viral mimetic polyri-
boinosinic–polyribocytidilic acid (Poly I:C) 
during pregnancy. Those offspring report-
edly show changes in brain morphology, 
physiology, chemistry as well as behaviours 
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Table 1 Sample size of each group and the sequence of 
behavioural testing
Experiments Control group Treatment group
Locomotor activity 10♀9♂ 10♀10♂




Prepulse inhibition 10♀11♂ 10♀9♂
♀, female;♂, male.
that are similar to changes observed in patients with 
SCZ.9 10 Specifically, prenatal Poly I:C treatment on the 
gestation date (GD) 9 leads to a pathological profile in 
the offspring characterised by suppression in exploratory 
behaviour, abnormalities in selective associative learning 
in the form of latent inhibition (LI) disruption and aboli-
tion of the US pre-exposure effect, impairments in sensor 
motor gating in the form of reduced prepulse inhibition 
(PPI), enhanced sensitivity to the indirect dopamine 
receptor agonist amphetamine and deficiency in spatial 
working memory when the demand on temporal reten-
tion is high.11 12 The findings from our group showed that 
the serum levels of cytokines (TNF-α and IL-10) in the 
offspring increased after an injection of Poly I:C in rats 
during early pregnancy, and the NF-кB inhibitor pyrroli-
dine dithiocarbamate suppressed the maternal immune 
response induced by Poly I:C and partially prevented 
the behavioural changes in the offspring that mimicked 
neurodevelopmental disorders.
It is well known that microglia activation can be visu-
alised in vivo using 11C-PK11195 (PK11195) positron 
emission tomography (PET).13 14 The present study was 
to quantify microglia activation in vivo in the mature 
offspring of rats exposed to Poly I:C during pregnancy 
using 11C-PK11195 PET and immunohistochemistry. The 
brain regions of interest (ROI) included the prefrontal 
cortex and hippocampus, which have been frequently 
reported to be involved in the pathogenesis of SCZ.
MeThOds And MATerIAls
Animals
Female and male-specific pathogen-free colony Sprague-
Dawley (SD) rats (10–12 weeks old) were obtained from 
the Laboratory Animal Center of Zhengzhou University 
(Zhengzhou, Henan, China) and individually housed in a 
temperature and humidity-controlled environment with 
a 12-hour light/12-hour dark cycle (lights on at 07:00). 
Food and tap water were available ad libitum. All animal 
experiments in the present study were approved by the 
Animal Care and Use Committee at Xinxiang Medical 
University, Xinxiang, China, where the experiment was 
carried out. After 2 weeks of acclimatisation, male and 
female rats were colocated overnight. Male rats were 
removed in the morning of the next day. The breeding 
was stopped until 18 pregnant rats were accomplished. 
The successful copulation verified by the presence of a 
vaginal plug was considered GD 1.
Modelling method
Eighteen pregnant rats were randomly divided into two 
groups. On GD 9, all pregnant dams were weighed, and 
received a single caudal vein injection of Poly I:C or 
saline. The treatment group was defined as the offspring 
of pregnant dams (n=9) that received a 10 mg/kg Poly I:C 
injection15 16; the control group included the offspring of 
pregnant dams (n=9) that received a 10 mg/kg saline 
injection. The injections were performed between 09:00 
and 10:00 to minimise the variability associated with 
diurnal rhythms.
behavioural assessment
The offspring were weaned at postnatal day 21. Four 
offspring were housed to a cage by sex and litter, and main-
tained undisturbed until 8 weeks of age. The gender ratio 
of the treatment group and control group was approxi-
mately 1:1. One of each littermate was randomly selected 
for behavioural testing. The number of subjects employed 
in the behavioural testing is summarised in table 1.
locomotor activity
An open-field test was used to assess locomotor activity in a 
100 cm× 100 cm× 30 cm box. Data collection was performed 
by the SMART video tracking program (Panlab, Spain). To 
begin testing, the animals were gently placed in the centre 
of the area, and allowed to explore for 30 min. Rats were 
tested for 60 min and data were captured.
latent inhibition
LI included both passive and active avoidance tasks.17 
The passive avoidance conditioning task was carried out 
over 2 days. On the training day, each rat was placed in 
the lighted compartment, facing away from the dark 
compartment. After 5 s, the door was lifted. As soon as 
the rat entered the dark compartment with all four paws, 
the guillotine door was closed. The latency from the 
time the door was lifted to the time the rat entered the 
compartment was recorded as T1. A foot shock (0.5 mA, 
2 s duration) was delivered 3 s after the door was closed. 
On the test day (24 hours after training), the same exper-
iment procedure was followed as on the training day. The 
latency from the time the door was lifted to the time the 
rat entered the compartment was recorded as T2. The rat 
then returned to the home cage. T was calculated as the 
difference between T1 and T2.
The active avoidance task is a fear-motivated associa-
tive avoidance test using an electric current as a source 
of punishment. In our study, the active avoidance condi-
tioning was carried out in a two-way shuttle box apparatus 
(Panlab). The subject acclimated to the training box for 
10 min before the electric bulb (10 W) (unconditioned 
stimulus) was turned on in the compartment where the 
rat was located. Thirty seconds later, an electric current 
(0.3 mA, 5 s) (conditioned stimulus) was delivered to 
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Figure 1 Group comparison of behavioural measures. (A) Locomotor activity as measured by the distance travelled in the 
open field during 60 min of treatment. (B) Latency in the passive avoidance task. (C) The rate of active avoidance conditioned 
response. (D) Prepulse inhibition (PPI)deficits.
the grid floor of the compartment. The electric current 
and the light were turned off simultaneously after the rat 
was transferred into a different compartment. Each rat 
received 100 trials per day for five consecutive days.18 The 
rate of active avoidance conditioned response was calcu-
lated as the total number of conditioned responses/500. 
A higher value indicated better learning and memory.
Prepulse inhibition
PPI is the normal suppression of a startle response when a 
low-intensity stimulus, which elicits little or no behavioural 
response, immediately precedes an unexpected stronger 
startling stimulus. The amount of PPI is expressed as 
the percentage decrease in the amplitude of the startle 
response caused by the presentation of the prepulse.
All test sessions were performed in a single chamber 
startle apparatus (QMC-I, Kunming Institute of Zoology, 
Chinese Academy of Sciences, China).17 One rat was 
tested during each experimental session. In the test 
session, the rats were acclimated in the testing cylinder 
for 5 min, during which time the rats received back-
ground noise of only 70 dB sound pressure level (SPL). 
The test began with six trials of a pulse-alone startle stim-
ulus, consisting of a 40 ms burst of white noise of 120 dB 
SPL. The session continued with 20 randomised trials, 
which included five trials of a pulse-alone stimulus and 
five trials of each of the three types of prepulse startles. A 
prepulse startle consisted of a prepulse (white noise at 2, 
4 or 8 dB SPL above the 70 dB SPL background), a 100 
ms interval and a startle pulse (40 ms, 120 dB SPL white 
noise). The interval length between the 20 randomised 
trials varied randomly from 8 to 23 s with an average of 
15 s. Startle responses were measured with the program 
developed by Kunming Institute of Zoology, Chinese 
Academy of Sciences, China. The amount of PPI was 
expressed as the percentage decrease in the amplitude 
of the startle response caused by the presentation of the 
prepulse. The amplitude of the startle response without 
a prepulse is p. When a weak stimulus is given prior to 
the startle reflex stimulus, the amplitude for the startle 
response is pp. The percentage of PPI for each rat was 
calculated as (1-pp/p)×100, which is proportional to the 
inhibitory effect of PPI. Using this description of PPI, a 
high degree of sensory motor gating is reflected in a high 
% PPI value, whereas a lower or no gating results in a 
small or negative % PPI value.
Micro-PeT/CT scan
11C-PK11195 was synthesised from the precursors 11C-Tri-
flate-CH3 (ABX Express, Germany) and PK11195, with a 
radiochemical purity of more than 98%, pharmaceutical 
specifications: specific activity 62.5 TBq/mol.
Rats were anaesthetised for the duration of the scan 
session with 5% isoflurane using a system built in-house, 
which combines the fixed output of a single vaporizer 
(3% oxygen) in variable ratios with pure oxygen so that 
the isoflurane concentration for each rat was individually 
adjustable. Each rat was injected with 1 mCi11C-PK11195 
through the caudal vein. Each rat was scanned for 30 min 
with its brain centred in the axial and transaxial fields 
of view (Explore VISTA Micro-PET/CT scanner from 
GE Healthcare, USA). The image data were sorted into 
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Figure 2 (A) the prefrontal cortex PET scan of the treatment 
group; (B) the prefrontal cortex PET scan of the control 
group; (C) the prefrontal cortex CT scan of the treatment 
group; (D) hippocampus PET scan of the treatment group; 
(E) hippocampus PET scan of the control group; (F) 
hippocampus CT scan of the control group. Each panel 
shows the sagittal, coronal and horizontal positions from 
left to right. Brighter areas reveal a higher uptake ratio in 
the brain.The treatment group combined more radioactive 
material than the control group in both brain areas.
three-dimensional sinograms, followed by attenuation and 
scatter corrections, Fourier rebinding and two-dimensional 
ordered-subset expectation maximisation reconstruction 
with two iterations and 50 subsets. The image pixel size was 
0.385×0.385×0.385 mm. For semiquantitative evaluation, 
the maximum uptake values were automatically measured 
three times in the ROIs (hippocampus and prefrontal 
cortex) and the uptake ratio was calculated.19
Immunohistochemistry
Rats were deeply anaesthetised and sacrificed by cervical 
dislocation. Brains were removed, fixed in 4% parafor-
maldehyde for 4–6 hours, dehydrated with 30% sucrose 
in phosphate-buffered saline (PBS) overnight, embedded 
with optimum cutting temperature compound, cut into 
10 μm thick sections serially using a freezing microtome 
(CM1950, Leica, Germany), mounted onto superfrost 
plus glass slides and stored at −70°C for immunohisto-
chemistry. Six sets of serial sections were obtained from 
each brain, and one of them was used for immunostaining.
Immunohistochemistry was performed as previously 
described.20 After being washed in PBS, endogenous 
peroxides were blocked by incubation in 0.3% hydrogen 
peroxide in 50% methanol in distilled water for 30 
min. Sections were washed in PBS and preincubated 
in a blocking solution containing 5% bovine serum 
albumin for 15 min at room temperature. Then sections 
were incubated in a humidified chamber with the rabbit 
primary antibody against CD11b (1:100; Boster Biolog-
ical Engineering, China) in PBS overnight at 4°C. After 
several washes in PBS, sections were incubated with bioti-
nylated goat anti-rabbit secondary antibody (1:100; Boster 
Biological Engineering) for 60 min at room tempera-
ture, followed by incubation with the streptavidin-bi-
otin-peroxidase complex method (Boster Biological 
Engineering). Following the PBS rinsing, the antigen-an-
tibody complexes were visualised using diaminobenzi-
dine (Boster Biological Engineering) as the chromogen. 
The immunohistochemical controls were performed as 
above, but with the omission of the primary antibodies. 
Eight sections were selected randomly from the hippo-
campus and prefrontal cortex in both groups. Six images 
were taken from each section using ×10 magnification 
randomly. Images were captured using a microscope 
(DM1000, Leica) and the DM2000 Image Acquisition 
and Analysis System. Image-Pro Plus software (V.6.0, 
Media Cybernetics, Silver Spring, MD, USA) was used for 
statistical analysis. Optical density (OD) value was used 
to quantify the CD11b positive cytoplasm. The OD values 
were positively correlated with the strength degree of 
the positive expressed area. OD value=integrated optical 
density/positive results area.
statistical analysis
All analyses were performed using the Statistical Package 
for the Social Sciences (SPSS V.20.0). Quantitative vari-
ables in group comparisons were analysed using the 
independent t-test. Sex differences were analysed using 
the independent Χ2 test. Pearson correlation was used 
to examine the relationships among behavioural, immu-
nohistochemistry and micro-PET/CT measures. Because 
there was no significant sex difference in any of the 
preliminary analyses performed, the male and female 
subjects were collapsed to enhance statistical power. 
Statistical significance was set at p<0.05 (two tailed).
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Figure 3 A:11C-PK11195 uptake ratio in the prefrontal cortex B:11C-PK11195 uptake ratio in hippocampus note: p1-p5 
means 5 time points11C-PK11195 uptake ratio in the prefrontal cortex; h1-h5 means 5 time points11C-PK11195 uptake ratio in 
hippocampus.
Figure 4 (A) CD11b-immunopositive cells in the control 
group (A, C) and thetreatment group (B, D) Group comparison 
of OD values in the prefrontal cortex and hippocampus
resulTs
behavioural measures
As shown in figure 1A, the treatment group had a signifi-
cantly higher locomotor activity than the control group 
(t=5.239,p=0.002).
During the passive avoidance task, the treatment group 
showed a significantly longer latency on the first day (T1) 
than the control group (t=2.548, p=0.036). However, there 
was no difference in latency on the second day (t=−1.452, 
p=0.161) between the two groups. Consequently, the 
treatment group showed significantly lower T values than 
the control group, reflecting their learning and memory 
abilities (t=−2.618, p=0.038) (figure 1B).
During the active avoidance task, the treatment group 
showed a significantly slower rate of conditioning than 
the control group (t=−4.749, p=0.005) (figure 1C).
For the PPI test, the treatment group showed significantly 
lower PPI values than the control group across different 
prepulse intensities (72dB: t=−2.603, p= 0.028; 74 dB: 
t=−2.520, p=0.047; 78 dB: t=−7.718, p< 0.001)(figure 1D).
Micro-PeT/CT scan
The isoquinoline PK11195 binds to the translocator 
protein (18 kDa), the expression of which is believed to be 
enhanced in microglia during activation.2111C-PK11195 
uptake ratio was significantly slower in both the hippo-
campus (t= −4.462, p= 0.001) and prefrontal cortex (t= 
−3.990, p= 0.003) in the treatment group compared with 
the control group (figures 2 and 3).
Immunohistochemistry
Most of the microglia cells in the control group were in a 
resting state. The PET scanning showed round or oval cell 
bodies(figure 4A: A-C). In the treatment group, most of the 
microglia cells were activated (figure 4A: B,D). There was 
a significant difference in the OD values of the two groups 
in the hippocampus and prefrontal cortex areas (hippo-
campus: t=8.204, p< 0.001; prefrontal: t= 6.995,p< 0.001)
(figure 4B).
Correlations data
Table 1 shows the correlations among the behavioural tests, 
micro-PET/CT scan and immunohistochemistry. There 
were significant positive correlations between the decay rate 
of the prefrontal cortex and PP2, PP4, PP8 in behavioural 
tests. There were significant negative correlations between 
the immunohistochemistry OD value of the prefrontal cortex 
brain areas and PP2, PP4, PP8 in the behavioural tests. Loco-
motor activity was significantly negatively correlated with the 
decay rate of PET/CT, and positively correlated with the OD 
value. Passive avoidance was significantly correlated with 
hippocampus area. Active avoidance was significantly nega-
tively correlated with the OD value and positively correlated 
with decay rate of PET/CT (table 2). Table 3 showed a 
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Table 2 Correlations analysis between behavioural measures and PET/CT11C-PK11195 rates of decay, as well as 
immunohistochemistry OD values
PET/CT11C-PK11195uptake ratio OD value
Prefrontal cortex Hippocampus Prefrontal cortex Hippocampus
Locomotor activity −0.651* −0.765** 0.697* 0.849**
  PPI
  PP2 0.586* 0.534 −0.649** −0.364
  PP4 0.632* 0.518 −0.632* −0.567
  PP8 0.750** 0.439 −0.814** −0.534
Passive avoidance
  T1 −0.458 −0.588* 0.450 0.599*
  T 0.467 0.598* −0.473 −0.648*
Active avoidance
(total number of conditioned responses/500)
0.701* 0.816** −0.789** −0.802**
Linear correlation analysis was used to calculatedata.
*P<0.05;**P<0.01.
OD, optical density; PET,positron emission tomography; PPI, prepulse inhibition.
Table 3 Correlations analysis between PET11C-PK11195 




  Prefrontal cortex −0.705* −0.473
  Hippocampus −0.467 −0.798**
Linear correlation analysis was used to calculate data.
*P<0.05;**P<0.01.
OD, optical density; PET,positron emission tomography.
correlation between the micro-PET/CT scan and immuno-
histochemistry. There were also significantly positive correla-
tions between the OD value and decay rate of PET/CT in 
the same brain area (table 3).
dIsCussIOn
Main findings
This study aims to investigate microglia activation in the 
offspring of rats exposed to Poly I:C during pregnancy 
using 11C-PK11195 micro-PET/CT and immunohistochem-
istry. Our study demonstrated activated microglia in the 
prefrontal cortex and hippocampus areas, and the microglia 
activation was associated with SCZ-like behaviours.
We choose 56 days’ offspring because: (1) the age of 56 
days means a mature state of SD rats; and (2) the experi-
mental rats in the literature are 56 days.7 In the preliminary 
experiment, we tried to use Iba-1 and CD11b, respectively, 
as the primary antibody for immunohistochemistry. The 
result was that CD11b was more suitable for this study.
As shown, the branches and processes of the microglia 
cells derived from the Poly I:C exposed SD rats were 
different from those of the control group. While microglia 
cells from the control group rats showed a more highly 
branched arborisation, indicative of a non-inflammatory 
state of microglia, the offspring from the Poly I:C-treated 
rats were not characterised by none or fewer branched 
cells, as characteristic for an activated and inflamma-
tory or phagocytic state of microglia.22 23Juckel and 
colleagues showed that offspring microglia from Poly 
I:C-treated mothers were morphologically characterised 
by a reduced arborisation indicative for a status of higher 
activation compared with the offspring microglia from 
vehicle-treated mice.23 A reduction in ramified microglia 
and the overactivation of microglia cells at a young 
age may have a detrimental impact on the response by 
these animals to future neurological insults or injury. 
Williamson 24and colleagues suggest that adult microglia 
arise exclusively from the population of resident macro-
phages, meaning a reduction in ramified or resting 
microglia from an early age may have an enduring impact 
on the function of these resistant macrophage-like cells.
In addition, there were significant positive relation-
ships between the results of the micro-PET/CT scan and 
those of the immunohistochemistry. Our findings suggest 
that prenatal Poly I:C-induced SCZ treatment showed 
active microglia in the hippocampus and prefrontal 
cortex brain areas. In a study of descendants of mice 
exposed to Poly I:C at embryonic day 9, a higher number 
and activation of microglia cells in the hippocampus, 
but not in the prefrontal cortex, existed at postnatal 
day 30.25 Several previous studies with C57BL/6J mice 
reported that active microglia cells were present in the 
prefrontal regions in chronic stress, and chronically avail-
able alcohol.26 The difference in the brain areas of the 
active microglia might be explained by the differences 
in the species of mice. Increasing evidence suggests a 
role for microglia in normal synaptic plasticity mecha-
nisms within the adult brain, including dendritic spine 
retreatment and elimination.27 Some researchers have 
demonstrated that microglia primed as a consequence of 
neonatal infection and that this priming leads to aberrant 
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Figure 5 Flowchart of the study.
production of IL-1 specifically during learning in adult-
hood.24 ‘Priming’ of microglia, as in a fetal inflammatory 
challenge such as that provided by Poly I:C, may result 
in exaggerated response to a subsequent insult,28 due to 
increased production of cytokines compared with the 
‘unprimed’ microglia.29 It is thought that this overpro-
duction of cytokines due to a subsequent and undetected 
insult or infection could be the underlying mechanism 
leading to postnatal cognitive abnormalities related to the 
prefrontal cortex.30 Importantly, the resident microglia of 
the hippocampus are a necessary component of normal 
memory formation.24Vinet and colleagues indicated that 
ramified microglia screen their microenvironment and 
additionally protect hippocampus neurons under patho-
logical conditions.31
Our study found that the activation of the microglia 
was associated with SCZ-like behaviours. These findings 
are consistent with several previous findings.32–34Ito and 
colleagues reported that changes in CA1 hippocampal c-FOS 
expression (an immediate early gene measure of neuronal 
activity) and in excitatory postsynaptic currents (measured 
in slices maintained in vitro) led them to conclude that the 
altered processing of object-place recognition was of hippo-
campal origin. Richetto 34and colleagues found that prenatal 
Poly I:C-induced immune activation led to an age-dependent 
decrease in GAD65 and GAD67 expression in the prefrontal 
cortex and hippocampus, two brain areas critically involved 
in (spatial) working memory.35 36 In a study of 16 patients 
with SCZ, functional connectivity indices in the left dorso-
lateral prefrontal cortex and the right hippocampal cortex 
were positively correlated with accuracy during the working 
memory task, while the connectivity strength in the right 
dorsolateral prefrontal cortex was negatively correlated 
with measures of the severity of the working memory task.37 
Furthermore, a recent study38 found that high-risk individ-
uals showed decreased activation compared with healthy 
controls in the inferior frontal and prefrontal cortex during 
a semantic working memory task.
In postmortem studies, activation of microglia has indeed 
been found in several patients with SCZ, especially in the 
frontal regions of brain.39–42 A previous study of 10 patients 
with recent-onset SCZ reported that compared with control 
subjects, the R-11C-PK11195 binding of total grey matter was 
increased in patients with SCZ.43 It is possible that microglia 
activation may play a possible or potential role in the neuro-
pathology of SCZ. Recently, two PET studies on SCZ versus 
controls showed lack of significant difference in neuroin-
flammation in treated patients with SCZ in the midst of a 
psychotic episode. The neuroinflammatory processes may 
take place early in disease progression or are affected by anti-
psychotic treatment.44 45
Compared with previous studies, the strengths of this 
study included the prenatal Poly I:C-induced immune 
activation treatment, the use of 11C-PK11195 as a trace of 
micro-PET/CT scan, combined with CD11b immunohis-
tochemistry and behavioural assessment.
limitations
However, the study also has several limitations: (1) it 
was only studied at one time point at day 56, so it is not 
possible to conclude how long this activation of microglia 
might exist; (2) a causal relationship between microglia 
and cytokines cannot be drawn from the study design.
Implications
Future studies are needed to dynamically track the in vivo 
microglia activation from an embryonic state to adult-
hood in the Poly I:C prenatal infection animal model, 
examine the levels of cytokines in the cerebral spinal 
fluid and peripheral tissue and investigate the interven-
tion strategies to prevent and treat SCZ-like behaviours.
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